The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Management of Brain Metastasis, Leptomeningeal Metastasis and Spinal Cord Compression

뇌신경계 전이 및 증상 조절: 뇌 전이, 연수막 전이, 척수신경압박

  • Roh, Sang-Young (Department of Medical Oncology, The Catholic University of Korea School of Medicine)
  • 노상영 (가톨릭대학교 의과대학 서울성모병원 종양내과)
  • Published : 2011.09.01
⟨ Previous Next ⟩

Abstract

Metastases involving central nervous system are relatively frequent in advanced cancer patients. The incidence of brain metastases has increased over time, probably as a result of advances in neuro-imaging procedures and improvements in the treatment of primary tumour and systemic disease, which has led to an increase of survival. Treatment for metastases involving central nervous systme includes corticosteroids, anticonvulsants to control seizures, surgery, radiotherapy, radiosurgery and chemotherapy. The appropriate aim of treatment is maintenance of quality of life.

Keywords

References

  1. Nguyen T, Deangelis LM. Treatment of bain metastases. J Support Oncol 2004;2:405-410 discussion 411-416.
  2. Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 2011;11:352-363. https://doi.org/10.1038/nrc3053
  3. Soffietti R, RudàR, Trevisan E. Brain metastases: current management and new developments. Curr Opin Oncol 2008;20:676-684. https://doi.org/10.1097/CCO.0b013e32831186fe
  4. Kienast Y, Winkler F. Therapy and prophylaxis of brain metastases. Expert Rev Anticancer Ther 2010:10:1763-1777. https://doi.org/10.1586/era.10.165
  5. Lagerwaard FL, Levendag PJ, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795-803. https://doi.org/10.1016/S0360-3016(98)00442-8
  6. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751. https://doi.org/10.1016/S0360-3016(96)00619-0
  7. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-514. https://doi.org/10.1016/j.ijrobp.2007.06.074
  8. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500. https://doi.org/10.1056/NEJM199002223220802
  9. Franzini A, Leocata F, Giorgi C, Allegranza A, Servello D, Broggi G. Role of stereotactic biopsy in multifocal brain lesions: considerations on 100 consecutive cases. J Neurol Neurosurg Psychiatry 1994;57:957-960. https://doi.org/10.1136/jnnp.57.8.957
  10. Engenhart R, Kimmig BN, Hover KH, et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradia Cancer 1993;71:1353-1361. https://doi.org/10.1002/1097-0142(19930215)71:4<1353::AID-CNCR2820710430>3.0.CO;2-6
  11. Auchter RM, Lamond JP, Alexander E, et al. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain meis. Int J Radiat Oncol Biol Phys 1996;35:27-35. https://doi.org/10.1016/S0360-3016(96)85008-5
  12. Carman TL, Kanner AA, Barnett GH, Deitcher SR. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J 2003;96:17-22. https://doi.org/10.1097/01.SMJ.0000047628.44490.B2
  13. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-590. https://doi.org/10.1002/ana.410330605
  14. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489. https://doi.org/10.1001/jama.280.17.1485
  15. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol 2010;22:627-635. https://doi.org/10.1097/CCO.0b013e32833de986
  16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology [Internet].:Central Nervous System Cancers, v.2.2011. [cited 2011 Aug 8]. Available from:http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  17. Beauchesne P. Intrathecal chemotherapy for treatment of leptomeningealdissemination of metastatic tumors. Lancet Oncol 2010;11:871-879. https://doi.org/10.1016/S1470-2045(10)70034-6
  18. Shiue K, Sahgal A, Chow E, et al. Management of metastatic spinal cord compression. Expert Rev Anticancer Ther 2010;10:697-708. Erratum in: Expert Rev Anticancer Ther 2010;10:1162. https://doi.org/10.1586/era.10.47
  19. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH.Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomized trial. Eur J Cancer 1994;30A:22-27.
  20. Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O.High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-144.
  21. Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-1257 . https://doi.org/10.1212/WNL.39.9.1255
  22. Klimo P Jr, Kestle JR, Schmidt MH. Treatment of metastatic spinal epidural disease: a review of the literature. Neurosurg Focus 2003;15:E1.
  23. Chamberlain MC, Kormanik PA. Epidural spinal cord compression: a single institution's retrospective experience. Neuro Oncol 1999;1:120-123.
  24. Rades D, Stalpers LJ, Hulshof MC, Zschenker O, Alberti W, Koning CC. Effectiveness and toxicity of single-fraction radio-therapy with 1 $\times$ 8 Gy for metastatic spinal cord compression. Radiother Oncol 2005;75:70-73. https://doi.org/10.1016/j.radonc.2004.12.013
  25. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-328. https://doi.org/10.1002/cncr.20756
  26. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375. https://doi.org/10.1200/JCO.2005.04.754
  27. Rades D, Stalpers LJ, Hulshof MC, et al. Comparison of 1 $\times$ 8 Gy and 10 $\times$ 3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2005;62:514-518. https://doi.org/10.1016/j.ijrobp.2004.10.005
  28. Rades D, Lange M, Veninga T, et al. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2009;73:228-234. https://doi.org/10.1016/j.ijrobp.2008.04.044
  29. Williams BJ, Fox BD, Sciubba DM, et al. Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine 2009;10:414-422. https://doi.org/10.3171/2009.1.SPINE08509
  30. Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine (Phila Pa 1976) 2001;26:818-824. https://doi.org/10.1097/00007632-200104010-00025
  31. Healey JH, Brown HK. Complications of bone metastases: surgical management. Cancer 2000;88(12 Suppl):S2940-S2951.
  32. Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004;9:188-196. https://doi.org/10.1634/theoncologist.9-2-188